Czech National Bank grew its stake in shares of Teradyne, Inc. (NASDAQ:TER – Free Report) by 4.5% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 44,558 shares of the company’s stock after acquiring an additional 1,906 shares during the period. Czech National Bank’s holdings in Teradyne were worth $21,559,000 at the end of the most recent quarter.
A number of other institutional investors also recently made changes to their positions in TER. State Street Corp boosted its stake in Teradyne by 0.9% in the 4th quarter. State Street Corp now owns 7,078,635 shares of the company’s stock valued at $1,370,141,000 after purchasing an additional 60,986 shares during the period. Ameriprise Financial Inc. increased its position in Teradyne by 3.0% during the 2nd quarter. Ameriprise Financial Inc. now owns 4,920,100 shares of the company’s stock worth $442,413,000 after buying an additional 143,058 shares during the period. Price T Rowe Associates Inc. MD lifted its holdings in shares of Teradyne by 18.6% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 4,203,546 shares of the company’s stock worth $813,640,000 after buying an additional 659,273 shares in the last quarter. Invesco Ltd. lifted its holdings in shares of Teradyne by 3.5% during the third quarter. Invesco Ltd. now owns 2,959,330 shares of the company’s stock worth $407,322,000 after buying an additional 99,864 shares in the last quarter. Finally, Morgan Stanley boosted its position in shares of Teradyne by 1.9% in the fourth quarter. Morgan Stanley now owns 2,442,014 shares of the company’s stock valued at $472,677,000 after acquiring an additional 45,089 shares during the period. Institutional investors own 99.77% of the company’s stock.
Teradyne Stock Down 1.4%
TER stock opened at $379.31 on Friday. Teradyne, Inc. has a 52 week low of $104.58 and a 52 week high of $487.91. The business has a 50-day simple moving average of $383.46 and a 200 day simple moving average of $342.55. The company has a market cap of $59.30 billion, a PE ratio of 52.03, a price-to-earnings-growth ratio of 0.78 and a beta of 1.78.
Insiders Place Their Bets
In other news, insider Shannon John Poulin sold 656 shares of the stock in a transaction dated Friday, May 22nd. The shares were sold at an average price of $355.00, for a total value of $232,880.00. Following the completion of the transaction, the insider owned 15,722 shares of the company’s stock, valued at approximately $5,581,310. This represents a 4.01% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CEO Gregory Stephen Smith sold 4,000 shares of the firm’s stock in a transaction that occurred on Monday, June 15th. The shares were sold at an average price of $423.03, for a total transaction of $1,692,120.00. Following the completion of the sale, the chief executive officer owned 120,470 shares in the company, valued at approximately $50,962,424.10. The trade was a 3.21% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders sold 14,261 shares of company stock worth $5,187,344. Company insiders own 0.19% of the company’s stock.
Analyst Ratings Changes
Several equities analysts recently commented on the stock. Citigroup upped their price target on shares of Teradyne from $325.00 to $400.00 and gave the company a “buy” rating in a research note on Thursday, April 30th. Zacks Research raised shares of Teradyne from a “hold” rating to a “strong-buy” rating in a report on Tuesday, May 12th. UBS Group increased their target price on shares of Teradyne from $440.00 to $500.00 and gave the stock a “buy” rating in a research report on Monday, July 20th. Morgan Stanley raised their target price on shares of Teradyne from $387.00 to $397.00 and gave the stock an “equal weight” rating in a report on Thursday, July 30th. Finally, Cantor Fitzgerald reiterated an “overweight” rating and issued a $550.00 price target on shares of Teradyne in a research report on Wednesday, July 29th. One research analyst has rated the stock with a Strong Buy rating, twelve have given a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat, Teradyne currently has an average rating of “Moderate Buy” and a consensus price target of $396.80.
Get Our Latest Research Report on Teradyne
About Teradyne
Teradyne, Inc is a global supplier of automatic test equipment and related services principally used to test semiconductors, wireless products and complex electronic systems. Founded in 1960, the company is headquartered in North Reading, Massachusetts, and has a long history of developing capital equipment and software that help semiconductor manufacturers, electronics OEMs and contract manufacturers validate product performance and reliability during design and production.
The company’s product portfolio centers on automatic test equipment (ATE) and system-level test solutions that address chip- and board-level validation, burn-in and reliability screening.
Featured Stories
- Five stocks we like better than Teradyne
- Datadog’s Drop Says More About Expectations Than Earnings
- D-Wave’s Quantum Breakthrough Couldn’t Save QBTS From a Sell-Off
- Cloudflare’s Beat-and-Raise Quarter Puts Its AI Edge Story in Focus
- Solventum Nears Inflection Point As It Begins to Unlock Value
Want to see what other hedge funds are holding TER? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teradyne, Inc. (NASDAQ:TER – Free Report).
Receive News & Ratings for Teradyne Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teradyne and related companies with MarketBeat.com's FREE daily email newsletter.
